SLS 8-K: Fda approval
SELLAS Life Sciences
Filed with the SEC on · accession 0001104659-26-128825
SLS filed a 8-K (current report) with the SEC on Nov 17, 2026. SELLAS Life Sciences announced positive topline results from the pivotal Phase 3 REGAL trial of galinpepimut-S (GPS) in acute myeloid leukemia (AML), meeting its primary overall survival endpoint with a 41% reduction in risk of death (HR 0.59, p=0.035) and median OS of 24.0 months versus 14.7…
Summary of the filing
SELLAS Life Sciences announced positive topline results from the pivotal Phase 3 REGAL trial of galinpepimut-S (GPS) in acute myeloid leukemia (AML), meeting its primary overall survival endpoint with a 41% reduction in risk of death (HR 0.59, p=0.035) and median OS of 24.0 months versus 14.7 months for best available treatment.
Key details
✦ Ask GOAX AI about this filing — what it means for SLS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SLS?
Click hereFrequently asked questions
What did SLS file with the SEC on Nov 17, 2026?
SLS filed a 8-K (Fda approval). SELLAS Life Sciences announced positive topline results from the pivotal Phase 3 REGAL trial of galinpepimut-S (GPS) in acute myeloid leukemia (AML), meeting its primary overall survival endpoint with a 41% reduction in risk of death (HR 0.59, p=0.035) and median OS of 24.0 months versus 14.7 months for best available treatment.
What does a fda approval mean for SLS stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other SLS SEC filings
- 8-K · SEC filingNov 12, 2026
- 10-Q · SEC filingNov 12, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingJul 27, 2026
- 8-K · SEC filingJun 25, 2026
- 8-K · SEC filingJun 18, 2026
- 8-K · SEC filingJun 2, 2026
Get alerts when SLS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days